Small Intestinal Cavernous Hemangioma Presenting with Recurrent Gastrointestinal Bleeding: A Case Report and Narrative Review Authors: Ya-Lin Liu, Hai-Rui Shang, Liang-Bi Xu, Xiao-Wen Xu, Yuan-Xue Ji, Yi-Yang He, Shao-Jie Chen Published: 2026 ABSTRACT Background Small intestinal cavernous hemangiomas are rare vascular malformations that present diagnostic and therapeutic challenges due to their deep location and propensity for recurrent bleeding. This report aims to describe a case with a sequential management approach and to synthesize existing evidence through a narrative literature review.Case Presentation: A 74-year-old female presented with recurrent melena for five months. Initial imaging (gastroscopy, colonoscopy, computed tomography angiography, and computed tomography enterography) revealed no bleeding source. Balloon-assisted enteroscopy identified a 0.6 cm mucosal protrusion 520 cm distal to the pylorus, with active oozing. Endoscopic hemostasis was achieved using metal clip occlusion and lauromacrogol sclerotherapy, following which a biopsy was performed safely to confirm the diagnosis of hemangioma. Six months later, melena recurred, and the patient underwent surgical resection of the same lesion. Pathological examination confirmed a cavernous hemangioma. At two-year follow-up, the patient remained free from recurrent gastrointestinal bleeding.Conclusion This case highlights the value of balloon-assisted enteroscopy for localizing obscure small intestinal bleeding and achieving temporary hemostasis. While endoscopic intervention facilitates diagnosis and acute bleeding control, surgical resection remains the definitive treatment for selected cases. Close follow-up may be considered to monitor for potential recurrence. A narrative review of the literature supports the rarity of this condition and the limited evidence base for treatment standardization. Introduction Hemangiomas are developmental vascular anomalies that may be classified as hamartomas, true benign tumors, or malformations. They are broadly categorized into infantile hemangiomas (IH) and congenital hemangiomas. Infantile hemangiomas are glucose transporter-1 (GLUT-1)-positive, typically emerge within the first two months of life, show rapid growth in the first year, and gradually regress thereafter. In contrast, congenital hemangiomas are present at birth, are GLUT-1-negative, and may become symptomatic due to growth, infection, hormonal changes, or trauma.1 When located in the gastrointestinal tract, hemangiomas are rare benign vascular tumors, accounting for approximately 0.3% of all gastrointestinal tumors.2 Small intestinal cavernous hemangiomas, a histological subtype of hemangiomas, present particular diagnostic and therapeutic challenges. Their submucosal location and propensity for obscure gastrointestinal bleeding often result in insidious clinical presentations, such as recurrent melena or chronic anemia, frequently leading to delayed diagnosis. Conventional imaging modalities, including gastroscopy, colonoscopy, and computed tomography angiography (CTA), exhibit low detection rates for these lesions due to the anatomical complexity and mobility of the small bowel. Although capsule endoscopy and balloon-assisted enteroscopy have improved diagnostic yield, the endoscopic appearance of small intestinal hemangiomas is diverse and can be difficult to distinguish from other submucosal lesions, such as gastrointestinal stromal tumors (GISTs), polyps, heterotopic pancreas, or lymphoma. Furthermore, endoscopic biopsy of suspected vascular lesions carries a substantial risk of inducing massive hemorrhage, limiting its routine use for pathological confirmation.3 Despite advances in diagnostic techniques, the optimal management strategy for small intestinal cavernous hemangiomas remains unclear. Current evidence is largely derived from isolated case reports, with limited data on treatment outcomes and long-term follow-up. Surgical resection has traditionally been considered the mainstay of curative treatment, but endoscopic interventions, including clipping, sclerotherapy, and endoscopic mucosal resection (EMR), have emerged as alternatives for acute bleeding control and lesion removal in selected cases.4 The heterogeneity of reported cases, coupled with inconsistent terminology and incomplete outcome reporting, complicates the formulation of standardized management recommendations. Case Presentation A 74-year-old female patient was admitted to our hospital with a chief complaint of recurrent melena for five months, with worsening episodes over the past month. Her medical history included a right knee arthroplasty performed six months prior and a 10-year history of hypertension, which was well controlled with oral antihypertensive medication. She denied use of anticoagulants, antiplatelet agents, or nonsteroidal anti-inflammatory drugs (NSAIDs). There was no history of peptic ulcer disease, liver cirrhosis, or previous gastrointestinal bleeding. On admission, vital signs were as follows: temperature 36.3°C, pulse 82 beats per minute, respiratory rate 20 breaths per minute, and blood pressure 159/88 mmHg. Physical examination revealed an anemic appearance with slightly pale palpebral conjunctiva. Cardiopulmonary auscultation was unremarkable. The abdomen was flat and soft, with no tenderness, rebound tenderness, or muscle guarding. The liver and spleen were not palpable below the costal margin, Murphy’s sign was negative, shifting dullness was negative, and bowel sounds were 4 times per minute. No edema was observed in the lower extremities. Laboratory tests on admission revealed: white blood cell (WBC) count 5.07×109/L (reference range: 3.5–9.5×109/L), hemoglobin (Hgb) 65 g/L (reference range: 115–150 g/L for females), hematocrit (HCT) 23.30%, and platelet (PLT) count 136.00×109/L (reference range: 125–350×109/L). Coagulation parameters, renal function, and liver function were within normal limits. The patient received supportive management including packed red blood cell transfusions and intravenous iron supplementation, with serial hemoglobin monitoring. Gastroscopy and colonoscopy revealed multiple benign polyps but no sources of bleeding. Small bowel computed tomography angiography (CTA) combined with computed tomography enterography (CTE) showed no definitive bleeding lesions. Given the negative findings and persistent melena, balloon-assisted enteroscopy was performed via the oral route under sedation. Approximately 520 cm distal to the pylorus, a 0.6 cm-diameter mucosal protrusion was identified, displaying redness, surface erosion, and fresh oozing blood (Figure 1A). A pathological biopsy was obtained from the lesion surface (Figure 1C). Subsequently, endoscopic hemostasis was achieved using two metal clips applied to the lesion (Figure 1B), followed by injection of 2 mL of lauromacrogol (1% concentration, mixed with methylene blue) into the base of the lesion to induce sclerosis (Figure 1D), and an additional metal clip was applied to close the puncture site. No active bleeding was observed at the end of the procedure (Figure 1E). The biopsy specimen confirmed the diagnosis of hemangioma (Figure 1F).Figure 1Endoscopic manifestations and management process of small intestinal hemangioma. (A) A mucosal elevation approximately 0.6 cm in diameter was observed about 520 cm from the pylorus, presenting with redness, erosion, and fresh bleeding. (B) The elevation was closed with two endoscopic metal clips. (C) Pathological biopsy was performed on the surface of the lesion. (D) 2 mL of lauromacrogol (mixed with methylene blue) was injected at the base of the elevation. (E) An additional metal clip was applied to ensure closure of the puncture site, with no active bleeding observed at the end of the procedure. (F) Biopsy pathology.Six-panel endoscopy series showing a bleeding bowel nodule treated with clips, injection and biopsy. Endoscopic manifestations and management process of small intestinal hemangioma. (A) A mucosal elevation approximately 0.6 cm in diameter was observed about 520 cm from the pylorus, presenting with redness, erosion, and fresh bleeding. (B) The elevation was closed with two endoscopic metal clips. (C) Pathological biopsy was performed on the surface of the lesion. (D) 2 mL of lauromacrogol (mixed with methylene blue) was injected at the base of the elevation. (E) An additional metal clip was applied to ensure closure of the puncture site, with no active bleeding observed at the end of the procedure. (F) Biopsy pathology. The patient was discharged in stable condition with scheduled follow-up. However, six months after the endoscopic intervention, melena recurred. Repeat balloon-assisted enteroscopy localized the same lesion in the mid-ileum, which had not changed substantially in appearance. Due to recurrent bleeding and the confirmed pathological diagnosis, surgical resection was recommended. Intraoperative localization was guided by preoperative endoscopic tattooing and palpation. The lesion was identified in the mid-ileum, approximately 0.6 cm in diameter, and did not protrude through the serosal layer. Its gross morphology was consistent with the previous endoscopic findings. Segmental resection of the involved small bowel with primary anastomosis was performed. The postoperative course was uneventful, and the patient recovered well. Pathological examination of the resected specimen confirmed cavernous hemangioma, with no evidence of malignancy. The patient was followed up regularly at our outpatient clinic. At two years post-surgery, she remained symptom-free, with no recurrent melena or anemia. Serial hemoglobin levels remained stable within the normal range. This case report follows the CARE (CAse REport) guidelines. The completed CARE checklist has been provided as a Supplementary File. Discussion We report a case of small intestinal cavernous hemangioma managed with a sequential approach of endoscopic hemostasis with biopsy followed by definitive surgical resection after recurrence. This case illustrates the diagnostic and therapeutic challenges posed by this rare vascular lesion and provides practical insights into management decision-making. Literature Review Methodology To contextualize our findings, we performed a narrative literature review. A comprehensive search was conducted in PubMed, Web of Science (including CNKI, Wanfang Data, and VIP Information) up to December 2025, without language restrictions. The Boolean search strategy employed: ((“ileum” OR “jejunum” OR “duodenum” OR “intestinal”) AND (“hemangioma”) AND (“cavernous”)). Corresponding Chinese search terms were used for the Chinese databases. Additional relevant studies were identified by manual screening of reference lists. Eligibility criteria included: (1) case reports or case series of small intestinal cavernous hemangioma; (2) sufficient clinical data regarding presentation, diagnosis, treatment, and outcome. A total of 28 case reports were included in the final analysis (Table 1)5–12 Table 1Clinical Characteristics of Previously Reported Cases of Small Intestinal Cavernous HemangiomaRefCountryCase No.Sex/AgeClinical PresentationDiagnostic ModalityEndoscopic FeatureLesion LocationSingle/MultipleSize (cm)TreatmentPathological Diagnosis[13]United States1M/71Anemia, hematocheziaBAEPolypoid submucosal lesionJejunumSingleNREMRCavernous hemangioma[14]Germany1M/23Anemia, hematocheziaCE, push enteroscopyBluish-red submucosal massJejunumSingle3.0Surgical resectionCavernous hemangioma[5]Croatia1M/73Chronic anemiaCE, BAEBluish vascular tumor-like structureIleumSingle2.0×2.0Surgical resectionCavernous hemangioma[15]Croatia2M/63Anemia, hematocheziaCEPolypoid bleeding submucosal lesionJejunum–ileum junctionSingle8.0Surgical resectionCavernous hemangioma[16]Japan1M/29Incidental findingDBEBluish vascular tumor-like structureIleumSingle15.0Surgical resectionCavernous hemangioma[17]Spain1M/70Chronic iron-deficiency anemiaCEMultiple red-purple submucosal massesJejunumSingleNRSurgical resectionCavernous hemangioma[18]China1M/50HematocheziaUpper endoscopyDark red submucosal lesionDuodenumSingleNRSurgical resectionCavernous hemangioma[6]China1M/20Recurrent hematocheziaDBESmooth submucosal bulgeIleumSingle1.2×1.0Surgical resectionCavernous hemangioma[7]United States1M/66Chronic anemiaCE, DBESoft submucosal massJejunumSingle2.5Surgical resectionCavernous hemangioma[8]United States1M/30Chronic anemiaCE, push enteroscopyBluish raised protruding lesionsJejunumMultipleNRSurgical resectionCavernous hemangioma[9]China1M/27HematocheziaCE, DBESubmucosal tumor with surface ulcer and active bleedingJejunumSingle0.7×0.7×0.6Surgical resectionCavernous hemangioma[19]Belgium1F/78Anemia, hematocheziaCE, antegrade enteroscopyNodular submucosal lesionJejunumSingle2.4Surgical resectionCavernous hemangioma[20]United States1F/81Massive hematocheziaCE, push enteroscopyPolypoid submucosal noduleJejunumSingleNRSurgical resectionCavernous hemangioma[21]Portugal1M/69Recurrent hematocheziaCE, BAEMultiple violaceous protruding lesionsIleumMultipleNRSurgical resectionCavernous hemangioma[10]Australia1M/19Chronic anemiaCE, DBESessile polypoid submucosal lesionsJejunum and ileumMultiple0.8, 1.2, 1.4EMRCavernous hemangioma[22]Japan1F/62HematocheziaCE, DBESolitary raised submucosal lesionJejunumSingle1.5Endoscopic clipping + surgical resectionCavernous hemangioma[23]Japan2M/53HematocheziaCE, DBESMT-type raised submucosal lesionIleumSingle1.0Surgical resectionCavernous hemangioma[24]United States1M/23Chronic anemiaCEPurple-blue subepithelial massIleumSingle3.0×2.5Surgical resectionCavernous hemangioma[25]Japan1M/86Chronic anemiaCE, DBEMucosal protrusion into jejunal lumenJejunumMultiple0.5, 0.7EMRCapillary hemangioma[26]France1F/32HematocheziaCEBlue submucosal lesion with superficial red erosionsJejunumSingle2.0Surgical resectionCavernous hemangioma[27]Spain1F/75Iron-deficiency anemiaCEViolet polypoid submucosal lesionJejunumSingle1.5Surgical resectionCavernous hemangioma[28]United States1M/62HematocheziaUpper endoscopyNRJejunumSingleNRSurgical resectionCavernous hemangioma[16]China1M/44Anemia, hematocheziaCEIrregular polypoid submucosal neoplasmJejunumSingleNRSurgical resectionCavernous hemangioma[24]China1F/24HematocheziaCE, BAEPurple raspberry-like submucosal lesionIleumSingle5.0×3.0×3.0Surgical resectionCavernous hemangioma[29]China1M/47HematocheziaDBENRIleumMultipleNRSurgical resectionCavernous hemangioma + arterial venous malformation[11]Spain1M/77Chronic anemiaCE, BAEPolypoid submucosal lesionJejunumSingle2.2Surgical resectionCapillary hemangioma[12]Portugal1F/9Anemia, hematocheziaCEBluish polypoid submucosal massIleumSingle2.0×2.5Surgical resectionCavernous hemangioma[30]Italy1M/13Chronic anemiaCELarge erythematous polypoid lesionIleumSingle2.0Surgical resectionCavernous hemangiomaAbbreviations: BAE, balloon-assisted enteroscopy; CE, capsule endoscopy; DBE, double-balloon enteroscopy; EMR, endoscopic mucosal resection; AVM, arteriovenous malformation; NR, not reported. Table 1Clinical Characteristics of Previously Reported Cases of Small Intestinal Cavernous HemangiomaRefCountryCase No.Sex/AgeClinical PresentationDiagnostic ModalityEndoscopic FeatureLesion LocationSingle/MultipleSize (cm)TreatmentPathological Diagnosis[13]United States1M/71Anemia, hematocheziaBAEPolypoid submucosal lesionJejunumSingleNREMRCavernous hemangioma[14]Germany1M/23Anemia, hematocheziaCE, push enteroscopyBluish-red submucosal massJejunumSingle3.0Surgical resectionCavernous hemangioma[5]Croatia1M/73Chronic anemiaCE, BAEBluish vascular tumor-like structureIleumSingle2.0×2.0Surgical resectionCavernous hemangioma[15]Croatia2M/63Anemia, hematocheziaCEPolypoid bleeding submucosal lesionJejunum–ileum junctionSingle8.0Surgical resectionCavernous hemangioma[16]Japan1M/29Incidental findingDBEBluish vascular tumor-like structureIleumSingle15.0Surgical resectionCavernous hemangioma[17]Spain1M/70Chronic iron-deficiency anemiaCEMultiple red-purple submucosal massesJejunumSingleNRSurgical resectionCavernous hemangioma[18]China1M/50HematocheziaUpper endoscopyDark red submucosal lesionDuodenumSingleNRSurgical resectionCavernous hemangioma[6]China1M/20Recurrent hematocheziaDBESmooth submucosal bulgeIleumSingle1.2×1.0Surgical resectionCavernous hemangioma[7]United States1M/66Chronic anemiaCE, DBESoft submucosal massJejunumSingle2.5Surgical resectionCavernous hemangioma[8]United States1M/30Chronic anemiaCE, push enteroscopyBluish raised protruding lesionsJejunumMultipleNRSurgical resectionCavernous hemangioma[9]China1M/27HematocheziaCE, DBESubmucosal tumor with surface ulcer and active bleedingJejunumSingle0.7×0.7×0.6Surgical resectionCavernous hemangioma[19]Belgium1F/78Anemia, hematocheziaCE, antegrade enteroscopyNodular submucosal lesionJejunumSingle2.4Surgical resectionCavernous hemangioma[20]United States1F/81Massive hematocheziaCE, push enteroscopyPolypoid submucosal noduleJejunumSingleNRSurgical resectionCavernous hemangioma[21]Portugal1M/69Recurrent hematocheziaCE, BAEMultiple violaceous protruding lesionsIleumMultipleNRSurgical resectionCavernous hemangioma[10]Australia1M/19Chronic anemiaCE, DBESessile polypoid submucosal lesionsJejunum and ileumMultiple0.8, 1.2, 1.4EMRCavernous hemangioma[22]Japan1F/62HematocheziaCE, DBESolitary raised submucosal lesionJejunumSingle1.5Endoscopic clipping + surgical resectionCavernous hemangioma[23]Japan2M/53HematocheziaCE, DBESMT-type raised submucosal lesionIleumSingle1.0Surgical resectionCavernous hemangioma[24]United States1M/23Chronic anemiaCEPurple-blue subepithelial massIleumSingle3.0×2.5Surgical resectionCavernous hemangioma[25]Japan1M/86Chronic anemiaCE, DBEMucosal protrusion into jejunal lumenJejunumMultiple0.5, 0.7EMRCapillary hemangioma[26]France1F/32HematocheziaCEBlue submucosal lesion with superficial red erosionsJejunumSingle2.0Surgical resectionCavernous hemangioma[27]Spain1F/75Iron-deficiency anemiaCEViolet polypoid submucosal lesionJejunumSingle1.5Surgical resectionCavernous hemangioma[28]United States1M/62HematocheziaUpper endoscopyNRJejunumSingleNRSurgical resectionCavernous hemangioma[16]China1M/44Anemia, hematocheziaCEIrregular polypoid submucosal neoplasmJejunumSingleNRSurgical resectionCavernous hemangioma[24]China1F/24HematocheziaCE, BAEPurple raspberry-like submucosal lesionIleumSingle5.0×3.0×3.0Surgical resectionCavernous hemangioma[29]China1M/47HematocheziaDBENRIleumMultipleNRSurgical resectionCavernous hemangioma + arterial venous malformation[11]Spain1M/77Chronic anemiaCE, BAEPolypoid submucosal lesionJejunumSingle2.2Surgical resectionCapillary hemangioma[12]Portugal1F/9Anemia, hematocheziaCEBluish polypoid submucosal massIleumSingle2.0×2.5Surgical resectionCavernous hemangioma[30]Italy1M/13Chronic anemiaCELarge erythematous polypoid lesionIleumSingle2.0Surgical resectionCavernous hemangiomaAbbreviations: BAE, balloon-assisted enteroscopy; CE, capsule endoscopy; DBE, double-balloon enteroscopy; EMR, endoscopic mucosal resection; AVM, arteriovenous malformation; NR, not reported. Clinical Characteristics of Previously Reported Cases of Small Intestinal Cavernous Hemangioma Abbreviations: BAE, balloon-assisted enteroscopy; CE, capsule endoscopy; DBE, double-balloon enteroscopy; EMR, endoscopic mucosal resection; AVM, arteriovenous malformation; NR, not reported. Clinical Significance and Diagnostic Challenges Small intestinal cavernous hemangiomas are rare benign vascular tumors, accounting for approximately 0.3% of all gastrointestinal tumors. According to recent literature, cavernous hemangiomas account for 7–10% of all benign small bowel tumors,27,31 with gastrointestinal bleeding being the most common clinical presentation, manifesting as recurrent melena or chronic iron-deficiency anemia. In a literature review of 20 pediatric cases, anemia (15 cases) and gastrointestinal bleeding (10 cases) were the predominant presentations,19 with cavernous hemangioma being the most frequent histological type and the jejunum the most common location.19,32 The insidious nature of these symptoms often leads to significant diagnostic delays, as observed in our patient, who experienced five months of recurrent melena before diagnosis. The anatomical location of the small intestine poses inherent diagnostic difficulties. Conventional upper and lower endoscopy cannot visualize the mid-intestine, and traditional imaging modalities such as CTA and CTE have limited sensitivity for detecting small or flat vascular lesions. In our case, both gastroscopy and colonoscopy, as well as CTA/CTE, failed to identify the bleeding source. This diagnostic challenge underscores the critical role of advanced enteroscopy techniques.33 Double-balloon enteroscopy (DBE) has significantly improved diagnostic yield for obscure gastrointestinal bleeding by enabling direct visualization and therapeutic intervention throughout the small bowel.34 In our patient, DBE successfully localized a 0.6 cm lesion 520 cm distal to the pylorus, which was not detected by cross-sectional imaging. This highlights the superiority of direct endoscopic visualization for identifying subtle mucosal and submucosal vascular lesions. The predominance of jejunal involvement observed in our literature review is consistent with previous reports, including a Chinese case series of a 44-year-old male with an irregular polypoid jejunal neoplasm.27 Endoscopic Features and Classification Endoscopically, cavernous hemangiomas typically appear as polypoid or submucosal masses with a blue, purple-red, or wine-red discoloration, reflecting the underlying vascular channels. Diffuse forms may present as segmental thickening with circumferential infiltration, potentially leading to stenosis or obstruction. In our case, the lesion appeared as a reddish mucosal protrusion with surface erosion and active oozing, consistent with the typical appearance of a bleeding vascular lesion. A wide spectrum of endoscopic appearances has been reported in the literature. Duodenal cavernous hemangioma may present as a dark red submucosal lesion.17 In the ileum, multiple violaceous or purple-red protruding lesions have been described in cases of multifocal involvement.16,20 Blue-colored lesions with superficial red spots have also been reported in the jejunum.24 Additionally, vascular malformations may coexist with cavernous hemangiomas, as reported in a case of ileal hemangioma with concurrent arteriovenous malformation,29 highlighting the importance of thorough vascular evaluation. The classification of gastrointestinal vascular lesions remains a subject of debate, and inconsistent terminology of cavernous hemangioma and venous malformation has long confused clinical diagnosis and treatment decision-making. The International Society for the Study of Vascular Anomalies (ISSVA) classification establishes a core binary framework separating proliferative vascular tumors from non-proliferative vascular structural malformations.35 A 2024 systematic overview by Vrinceanu et al further refined this distinction and clarified the historical nomenclature confusion between cavernous hemangioma and venous malformation, providing translational classification guidance applicable to visceral gastrointestinal lesions.36 In their work, Vrinceanu et al underlined a fundamental biological difference: true hemangiomas are benign vascular tumors driven by active endothelial proliferation, featuring distinct proliferative and involution phases, while vascular malformations are developmental structural defects with static endothelial turnover, growing proportionally with the patient’s somatic growth rather than undergoing spontaneous regression.36,37 Notably, the term “cavernous hemangioma” originated from early histological descriptions of lesions with dilated venous lumens, yet modern vascular anomaly taxonomists increasingly reclassify many previously labeled cavernous hemangiomas as low-flow venous malformations, especially those arising within the gastrointestinal submucosa.36 Cavernous lesions of the small intestine occupy an ambiguous intermediate zone in this classification system. In our case, pathological examination revealed diffusely dilated, thin-walled venous channels lined by mature flattened endothelium, absent mitotic activity or endothelial hyperplasia, and no proliferative vascular buds characteristic of classic infantile hemangioma. These histological features align more closely with venous malformation per the updated ISSVA and Vrinceanu’s refined categorization, yet we retain the term “small intestinal cavernous hemangioma” in this manuscript for consistency with decades of published gastrointestinal case reports, to avoid terminology disconnect for clinical readers. This dual naming convention creates practical diagnostic challenges: lesions with identical endoscopic appearance may be labeled either cavernous hemangioma or venous malformation across different case series, contributing to heterogeneous pooled data in literature reviews. Vrinceanu’s analysis also highlighted clinical consequences of misclassification: true proliferative hemangiomas carry higher risks of rapid expansion and recurrent bleeding after incomplete endoscopic sclerotherapy, while venous malformations feature deeper submucosal vascular plexuses that predispose to persistent hemorrhage after superficial endoscopic intervention.36 This distinction directly explains the clinical trajectory of our patient, in whom initial endoscopic clipping and lauromacrogol sclerotherapy only achieved temporary hemostasis, with recurrent melena occurring six months later due to residual deep venous vascular channels unaddressed by superficial endoscopic therapy.4 For clinicians managing obscure small intestinal bleeding, standardized pre-treatment classification of submucosal vascular lesions—guided by the framework proposed by Vrinceanu et al—is critical to selecting individualized endoscopic versus surgical treatment strategies. Biopsy Considerations and Risks A critical consideration in the management of suspected vascular lesions is the risk of biopsy-induced hemorrhage. Endoscopic biopsy of a vascular lesion can precipitate life-threatening bleeding. As emphasized in the literature, endoscopic treatment of intestinal hemangioma should be prudent, as hemangiomas may sometimes involve the entire wall of the intestine, and endoscopic intervention may lead to uncontrolled bleeding or perforation. In our case, biopsy was performed only after achieving adequate hemostasis with metal clip occlusion and lauromacrogol injection. This sequential approach—hemostasis first, biopsy second—allowed for safe pathological confirmation without precipitating active bleeding. We emphasize that this strategy should not be generalized as routine practice for all suspected vascular lesions but may be considered in selected cases where hemostasis can be reliably achieved prior to tissue sampling.3,38,39 Treatment Strategies and Outcomes The optimal treatment for small intestinal cavernous hemangiomas depends on lesion characteristics, clinical presentation, anatomical location, and available expertise. In our case, endoscopic intervention achieved temporary hemostasis and facilitated pathological diagnosis, but recurrence at six months necessitated surgical resection.23 This sequence demonstrates that while endoscopy is valuable for localization and acute bleeding control,32 it may not eradicate the lesion entirely, particularly when it involves the submucosa.40 Recent evidence supports the feasibility of endoscopic injection sclerotherapy for small bowel hemangiomas.39 Liu et al reported a case of a 52-year-old woman with a 2.0 cm jejunal hemangioma treated successfully with DBE-guided endoscopic injection sclerotherapy using 8 mL of polidocanol-methylene blue mixture; the patient remained recurrence-free at one-year follow-up. The authors concluded that this procedure is simple, effective, convenient, and should be considered a preferred treatment option, particularly in patients with recurrent episodes or those unsuitable for surgery. In our patient, the lesion was smaller (0.6 cm) and sclerotherapy with lauromacrogol was performed, but recurrence still occurred at six months. This suggests that while sclerotherapy can achieve temporary hemostasis, the durability of response may vary based on lesion depth and vascular architecture.38 Surgical resection remains the gold standard for symptomatic hemangiomas, particularly for life-threatening complications such as hemorrhage, obstruction, or perforation. In our literature review of 28 cases, the majority of patients underwent surgical resection with favorable outcomes.31 For small, pedunculated, or superficial lesions, endoscopic mucosal resection (EMR) has been reported as a successful alternative in selected cases, including a 71-year-old male with a jejunal lesion,13 a 19-year-old male with multiple jejunal and ileal lesions,21 and a 20-year-old male with a 1.2 cm ileal lesion.18,23 However, Hu et al28 noted that endoscopic treatment should be prudent and may be suitable for multiple and relatively small lesions, whereas laparoscopic excision might be a better approach for large and diffuse lesions. Kano et al reported that even a 15 cm cavernous hemangioma could be resected using laparoscopy and mini-laparotomy due to its compressible nature.15 Additional surgical cases have been reported in patients of varying ages, including a 23-year-old male with a 3 cm jejunal lesion,14 a 75-year-old female with a 1.5 cm jejunal lesion,25 a 62-year-old male with a jejunal lesion,26 a 13-year-old male with a 2 cm ileal lesion,30 and a 23-year-old male with a 3×2.5 cm ileal lesion.22 For children, transumbilical single-site laparoscopic resection offers the benefits of minimal invasiveness, rapid recovery, and excellent cosmetic outcomes.40 The authors noted that since hemangiomas are benign tumors that do not metastasize, local resection is sufficient, and endoscopic treatments carry risks of uncontrolled bleeding, perforation, and high recurrence rates. The recurrence of bleeding in our case, despite successful initial endoscopic hemostasis, may be explained by incomplete treatment of deeper vascular channels, recanalization of residual components, or treatment-related injury. These possibilities highlight the limitations of endoscopic monotherapy for submucosal vascular lesions. Recommendations and Clinical Implications Based on our experience and literature review, we propose the following considerations for managing small intestinal cavernous hemangiomas: for suspected bleeding lesions identified during enteroscopy, endoscopic hemostasis with clipping or sclerotherapy is a reasonable initial approach for acute bleeding control; biopsy of vascular lesions should be approached with caution, and if tissue diagnosis is deemed essential, hemostasis should be secured prior to sampling; endoscopic injection sclerotherapy is a viable option for small bowel hemangiomas, although its durability requires further investigation;38,39 endoscopic treatment may provide temporary control and aid in localization, but definitive management often requires surgical resection, particularly for submucosal or larger lesions; individualized decision-making should account for lesion characteristics, patient comorbidities, and institutional expertise; and close follow-up is advisable given the potential for recurrence, though the prognosis is generally favorable with complete resection. Limitations Several limitations of this report should be acknowledged. First, this is a single-case report, which limits the generalizability of our observations. Second, the retrospective nature of the report precludes standardized data collection and may introduce recall bias. Third, the exact cause of recurrence—whether due to incomplete treatment, treatment-related injury, or lesion progression—remains uncertain. Fourth, the decision to perform biopsy after hemostasis, while safely executed in this case, may not be appropriate for all vascular lesions and should not be interpreted as a general recommendation. Fifth, the literature review is limited by publication bias, heterogeneity of terminology, incomplete reporting in published cases, and variability in follow-up duration. Finally, long-term recurrence risk beyond the one-year follow-up period in our patient remains unknown. Prospective studies or larger case series are needed to better define the natural history and optimal management of this rare condition. Conclusion This case report describes a 74-year-old female with small intestinal cavernous hemangioma managed through a sequential approach of endoscopic hemostasis with biopsy followed by definitive surgical resection after recurrence. The case illustrates the diagnostic value of balloon-assisted enteroscopy in localizing obscure small intestinal bleeding lesions and the limitations of endoscopic monotherapy for submucosal vascular lesions. Based on our experience and literature review, endoscopic intervention serves as a valuable tool for acute bleeding control and preoperative localization, while surgical resection remains the definitive treatment for lesions with recurrent bleeding or submucosal involvement. Individualized treatment decisions should consider lesion characteristics, patient comorbidities, and institutional expertise, with close follow-up recommended to monitor for potential recurrence. Given the rarity of this condition and the limited evidence available, further prospective studies or larger case series are warranted to establish standardized management guidelines and better define the long-term outcomes of different treatment modalities.